Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Oct 6, 2021
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-10-04$7.23/sh−64$462→ 54,319 total
Footnotes (2)
- [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- [F2]Includes 47,175 restricted stock units.